Visionary Ventures is a venture capital fund based in Newport Beach, California, that invests in life sciences, ophthalmology, and medical aesthetics. The firm leverages an information advantage strategy to connect capital and insight with promising startups from Series A through commercialization.
60% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (1 deal in the last 12 months vs 4 prior). Average disclosed round size is $46.6M (across 23 rounds with reported amounts).
Portfolio
16
Fund Size
$114M
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
30 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Pelage Pharmaceuticals | Series B | $120M | Oct 2025 |
| IIantrek | Series C | $42M | Aug 2025 |
| PPlatter | Pre-Seed | — | May 2025 |
| IIantrek | Series C | — | Jan 2025 |
 Orasis | Series D | $78M | Oct 2024 |
 Orasis Pharmaceuticals | Series D | $78M | Oct 2024 |
 ONL Therapeutics | Unknown | $65M | Sep 2024 |
| Pelage Pharmaceuticals | Series A | $14M | Feb 2024 |
| ONL Therapeutics | Series D | $65M | Jan 2024 |
 Re-Vana Therapeutics | Series A | $11.9M | Nov 2022 |
 Aurion | Series C | $120M | Apr 2022 |
 Aurion Biotech | Series A | $120M | Jan 2022 |
| Aurion | Series A | — | Jan 2022 |
| Re-Vana Therapeutics | Unknown | $11.9M | Jan 2022 |
| Orasis Pharmaceuticals | Series B | $13M | Sep 2020 |
 TearClear | Series B | $22M | Aug 2020 |
 Tarsus Pharmaceuticals | Series B | $60M | Jan 2020 |
| Orasis Pharmaceuticals | Series C | $30M | Jan 2020 |
| Orasis | Series C | $30M | Jan 2020 |
| Re-Vana Therapeutics | Series A | $2M | Jan 2020 |
| Aurion Biotech | Series B | — | Invalid Date |
| TearClear | Series A | $4.5M | Jan 2017 |
| Re-Vana Therapeutics | Seed | $1.6M | Jan 2017 |
 Sydnexis, Inc. | Series B | $45M | — |
| RRECCE | Unknown | $4M | — |
Page 1 of 2
Top Co-Investors
Bluestem Capital Company9 shared
Sequoia Capital5 shared
YK Bioventures4 shared
GV4 shared
ARCH Venture Partners4 shared
Main Street Advisors4 shared
Johnson & Johnson Innovation4 shared
Techstart Ventures4 shared
Catalio Capital Management3 shared
LifeSci Venture Partners3 shared
Deerfield3 shared
Maverick Ventures2 shared
aMoon2 shared
U.S. Venture Partners2 shared
Trinity Capital Inc.2 shared
Sectoral Asset Management2 shared
Civilization Ventures2 shared
Novartis Venture Fund2 shared
Maverick Ventures Israel2 shared
e2vc2 shared
Last updated: 20 October 2026